Sigilon - Ownership and Business Overview

Life ScienceCompany

Sigilon Ownership

Who owns Sigilon?

Sigilon is owned by Eli Lilly. It was acquired on June 29, 2023.

Sigilon Business Overview

Where is Sigilon headquartered?

Sigilon is headquartered in Cambridge, Massachusetts.

What is Sigilon’s revenue?

Sigilon disclosed revenue of 13M USD for 2020 and 14M USD for 2019.

What sector is Sigilon in?

Sigilon is a life science company.

When was Sigilon founded?

Sigilon was founded in 2015.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 201 acquisitions of life science companies in 2023, including 25 acquisitions by private equity firms, and 176 by strategics.

Sigilon

Sigilon Therapeutics, Inc.

100 Binney Street, Suite 600,
Cambridge, Massachusetts 02142
United States,
(617) 336-7540
www.sigilon.com

Sigilon is a biopharmaceutical company that develops functional cures for patients with chronic diseases. Its lead product candidate is SIG-001, which is in Phase I/II clinical trial to prevent bleeding episodes in patients with moderate-severe to severe Hemophilia A. The company is also developing SIG-005 to treat the non-neurological manifestations of the disease in patients with mucopolysaccharidosis type 1; and SIG-002 designed to replace islet cells for the treatment of type 1 diabetes. Sigilon was formed in 2015 and is based in Cambridge, Massachusetts.


 Subscribe to unlock this and 207,600
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.